Blueberries Medical Announces Closing of US$1.1 Million Non-Brokered Private Placement, reports 2022 Q3 Financial Results and provides Corporate and Operations Update
November 28, 2022 17:00 ET
|
Blueberries Medical Corp.
TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”), a Latin American licensed producer of medicinal cannabis and...
Blueberries Medical Reports 2022 Q1 Financial Results and Provides Corporate and Operations Update
May 30, 2022 17:23 ET
|
Blueberries Medical Corp.
TORONTO, May 30, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...
Blueberries Medical Reports 2021 Q3 Financial Results and Provides Corporate and Operations Update
November 29, 2021 07:30 ET
|
Blueberries Medical Corp.
TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...
Blueberries Medical Announces that its wholly subsidiary Blueberries SAS at Bogota, Colombia has made one of the biggest exports of Premium CBD Full Spectrum Oil of all time, scaling up its business to a level that will improve life condition of more than 2.500 patients in Peru
October 04, 2021 07:30 ET
|
Blueberries Medical Corp.
TORONTO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
Blueberries Medical Announces Closing of the Acquisition of BBV Labs – A Milestone in its Argentina Project
December 04, 2020 07:30 ET
|
Blueberries Medical Corp.
TORONTO, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Further to its news releases dated March 26, April 4, and July 2, 2019, Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or...
Blueberries Medical Announces Approval of Nine Psychoactive Strains, Corporate Update
October 26, 2020 07:30 ET
|
Blueberries Medical Corp.
TORONTO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
Blueberries Medical to Webcast Live at VirtualInvestorConferences.com on September 10th
September 08, 2020 07:30 ET
|
Blueberries Medical Corp.
TORONTO, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE:BBM) (OTCQB: BBRRF) (FRA: 1OA), (the “Company” or "Blueberries"), a Latin American, licensed producer of medicinal cannabis...
Blueberries Announces Strategic Investor & Closing of $1.0 Million Financing
July 16, 2020 07:30 ET
|
Blueberries Medical Corp.
TORONTO, July 16, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
Blueberries Announces Strategic Partnership with medcann
June 08, 2020 07:30 ET
|
Blueberries Medical Corp.
TORONTO, June 08, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
Blueberries Medical Granted Cultivation License for up to 37 Acres of Outdoor Production at Second Cultivation Property, Signs Letter of Intent to Commence Low-Cost Outdoor Production
April 23, 2020 07:30 ET
|
Blueberries Medical Corp.
TORONTO, April 23, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis...